EXEL
Price
$45.60
Change
+$0.81 (+1.81%)
Updated
Jul 25 closing price
Capitalization
12.44B
2 days until earnings call
VOR
Price
$2.20
Change
+$0.03 (+1.38%)
Updated
Jul 25 closing price
Capitalization
274.91M
12 days until earnings call
Interact to see
Advertisement

EXEL vs VOR

Header iconEXEL vs VOR Comparison
Open Charts EXEL vs VORBanner chart's image
Exelixis
Price$45.60
Change+$0.81 (+1.81%)
Volume$3.57M
Capitalization12.44B
Vor Biopharma
Price$2.20
Change+$0.03 (+1.38%)
Volume$3.11M
Capitalization274.91M
EXEL vs VOR Comparison Chart in %
Loading...
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXEL vs. VOR commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXEL is a StrongBuy and VOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (EXEL: $45.60 vs. VOR: $2.20)
Brand notoriety: EXEL: Notable vs. VOR: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXEL: 116% vs. VOR: 13%
Market capitalization -- EXEL: $12.44B vs. VOR: $274.91M
EXEL [@Biotechnology] is valued at $12.44B. VOR’s [@Biotechnology] market capitalization is $274.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXEL’s FA Score shows that 2 FA rating(s) are green whileVOR’s FA Score has 0 green FA rating(s).

  • EXEL’s FA Score: 2 green, 3 red.
  • VOR’s FA Score: 0 green, 5 red.
According to our system of comparison, EXEL is a better buy in the long-term than VOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXEL’s TA Score shows that 3 TA indicator(s) are bullish while VOR’s TA Score has 6 bullish TA indicator(s).

  • EXEL’s TA Score: 3 bullish, 4 bearish.
  • VOR’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, VOR is a better buy in the short-term than EXEL.

Price Growth

EXEL (@Biotechnology) experienced а +2.54% price change this week, while VOR (@Biotechnology) price change was -0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

EXEL is expected to report earnings on Nov 04, 2025.

VOR is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXEL($12.4B) has a higher market cap than VOR($275M). VOR YTD gains are higher at: 98.198 vs. EXEL (36.937). EXEL has higher annual earnings (EBITDA): 844M vs. VOR (-118.74M). EXEL has more cash in the bank: 1.03B vs. VOR (60M). VOR has less debt than EXEL: VOR (30.8M) vs EXEL (187M). EXEL has higher revenues than VOR: EXEL (2.3B) vs VOR (0).
EXELVOREXEL / VOR
Capitalization12.4B275M4,509%
EBITDA844M-118.74M-711%
Gain YTD36.93798.19838%
P/E Ratio20.82N/A-
Revenue2.3B0-
Total Cash1.03B60M1,718%
Total Debt187M30.8M607%
FUNDAMENTALS RATINGS
EXEL: Fundamental Ratings
EXEL
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
21
SMR RATING
1..100
32
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EXELVOR
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
64%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIGY2.80N/A
N/A
Sigyn Therapeutics Inc.
RNDOF9.88N/A
N/A
Round One Corp.
CDOAF5.50N/A
N/A
CDON AB
QBCRF29.31-0.19
-0.63%
Quebecor Inc.
CICOF1.73-0.03
-1.98%
COSCO SHIPPING Holdings Co Ltd.